Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Universidad italiana busca una empresa para producir nanoportadores específicos

Resumen

Tipo:
Demanda Tecnológica
Referencia:
TRIT20170207001
Publicado:
10/02/2017
Caducidad:
10/02/2018
Resumen:
Un equipo italiano de investigación médica busca un socio que ofrezca nanopartículas lipídicas sólidas de grado GMP (buenas prácticas de manufactura) para uso en animales y humanos. La tecnología debe desarrollarse/adaptarse a una molécula hidrofóbica específica que está estudiando el equipo de investigación. Esta molécula ha sido ampliamente investigada por su actividad terapéutica en diversas patologías y dispone de una patente. La universidad busca una compañía privada con el fin de establecer un acuerdo de cooperación técnica.

Details

Tittle:
Italian university is looking for a company able to produce specific nanocarriers
Summary:
An Italian medical research group is looking for a partner able to provide GMP (good manufacturing practices) grade solid lipid nanoparticles for animal and for human use. The technology should be developed/adapted to load a specific hydrophobic molecule that the group is studying. The university group is willing to sign a technical cooperation agreement with a private company.
Description:
A research department of a major Italian university devoted to biochemistry, lifesciences and medical research is looking for a specific technology.
Research carried out by the group proved that a orphan drug is able to significantly reduce oxidative stress and inflammation upon reperfusion of ischemic myocardium. The compound is delivered via solid lipid nanocarriers, and used as post conditioning therapy. It obtained a reduction of infarcted area and a amelioration of myocardial condition.
The group is now searching for a partner able to produce solid lipid nanoparticles that are loaded with a small hydrophobic molecule. This molecule has been extensively investigated by the research group for its therapeutic activity in different pathologies and a patent has already been filed and obtained. The filing of a second patent related to its application is under way. Now the group needs to be able to deliver the molecule with GMP (good manufacturing practices)-grade nano-carriers to develop a clinical trial in humans. The university group is ready to sign a technical cooperation agreement.
Technical Specification or Expertise Sought:
The nanoparticles will be applied for an innovative therapeutic approach of post conditioning in the therapy of myocardial reperfusion damage. The company should be already authorized to produce GMP-compliant nano-carriers and should have previous experience in the production of the specific type of nano-carriers required (solid lipid nanoparticles).

Partner sought

Type and Role of Partner Sought:
The partner should be a company already authorized to produce GMP-compliant nano-carriers and should have previous experience in the production of the specific type of nano-carriers required (solid lipid nanoparticles). The partner will sign a technical cooperation agreement with the research group to provide the nano-carriers required, including possible adaptations.

Client

Type and Size of Client:
University
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
English